Methotrexate and Mycophenolate Mofetil for UVEITIS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Victorian Eye and Ear Hospital
Melbourne, Victoria, Australia
- Aravind Eye Hospital
Coimbatore, Tamil Nadu, India
- Aravind Eye Hospital
Madurai, Tamil Nadu, India
- Aravind Eye Hospital
Pondicherry, Tamil Nadu, India
- Asociacion Para Evita la Ceguera En Mexico
Mexico City, Mexico City, Mexico
- King Khaled Eye Specialist Hospital
Riyadh, Saudi Arabia
- Francis I Proctor Foundation
San Francisco, California, United States
- Northwestern University
Chicago, Illinois, United States
- Oregon Health and Science University - Casey Eye Institute
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2013
- Primary completion
- 21 Feb 2018
- Completion
- 9 Aug 2018
- Last update posted
- 2 Apr 2024
- Registered enrollment
- 216
- Registry id
- NCT01829295
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.